ClinicalTrials.Veeva

Menu

Capnography Monitoring in Ventilated Children

V

Vincenzo Cannizzaro

Status

Unknown

Conditions

Heart Defects, Congenital
Lung Diseases, Interstitial
Lung Diseases, Obstructive
Child, Only
Critical Illness
ARDS, Human
Infant, Newborn, Diseases

Treatments

Diagnostic Test: capnography monitoring
Diagnostic Test: arterial blood gas

Study type

Observational

Funder types

Other

Identifiers

NCT04354220
KISPI-CAPNO

Details and patient eligibility

About

End-tidal CO2 measurements in children will be assessed for their accuracy with arterial CO2 measurements.

Full description

End-tidal and arterial CO2 measurements will be performed in invasively and non-invasively ventilated critically ill children. The endtidal CO2 values will assessed for their accuracy with respect to different underlying diseases and conditions of the children.

Enrollment

178 patients

Sex

All

Ages

1 hour to 13 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Children on pressure controlled mechanical invasive or non-invasive ventilation on the Paediatric Intensive Care Unit of the University Children's Hospital Zurich
  • Newborns with a birthweight of at least 2.0 kg
  • Newborns with an age of at least 1 hour (age > 60 minutes)
  • Children up to the last day of the 13th year of living
  • Ability of care taker or patient to understand verbal and written instructions and the general consent or informed consent in German or English
  • Obtained written general or informed consent as documented by signature
  • Available arterial line, i.e. a specific catheter inserted in an artery

Exclusion criteria

  • Care taker or participant unable for linguistic, mental or other reasons or unwilling to understand verbal or written information and to give written informed consent in German or English
  • Care taker not available
  • Newborns with a birthweight below 2.0 kg
  • Newborns younger than 1 hour (age <60 minutes)
  • Children with an age of 14 years onwards
  • Missing arterial line
  • Patients dependent on any other kind of respiratory support that is not compatible with the PcCO2-sensor or where a high leakage in the respiratory circuit makes PcCO2 measurements impossible (nasal mask ventilation, low-flow-/high-flow-ventilation, rebreathing mask, high- frequency-oscillation)
  • Patients where the investigators act on the assumption that mechanical ventilation will be discontinued and/or the arterial line will be removed within 6 hours or where only one pair of values (arterial and endtidal CO2) can be compared
  • Patients with a cyanotic shunt lesion with a weight of 15 kg or above

Trial design

178 participants in 4 patient groups

no shunt, no lung injury
Description:
ventilated newborns / infants / children with healthy lungs and without or corrected congenital heart disease and no intra-/extra-cardiac shunt
Treatment:
Diagnostic Test: arterial blood gas
Diagnostic Test: capnography monitoring
mild lung injury
Description:
ventilated newborns / infants / children with mild lung injury (OI between 4 and 8)
Treatment:
Diagnostic Test: arterial blood gas
Diagnostic Test: capnography monitoring
moderate-severe lung injury
Description:
ventilated newborns / infants / children with moderate or severe lung injury (OI above 8)
Treatment:
Diagnostic Test: arterial blood gas
Diagnostic Test: capnography monitoring
shunt lesion
Description:
ventilated newborns / infants / children with cyanotic heart diseases and therefore existing intra-cardiac or extra- cardiac right-left shunt lesions
Treatment:
Diagnostic Test: arterial blood gas
Diagnostic Test: capnography monitoring

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems